Mallinckrodt Plc (NYSE:MNK)

16.71
Delayed Data
As of Feb 20
 -0.09 / -0.54%
Today’s Change
15.27
Today|||52-Week Range
55.32
-25.93%
Year-to-Date
Arnold Schneider Adds to Chesapeake Energy, Mallinckrodt Positions
Feb 15 / GuruFocus News - Paid Partner Content
8 Stocks Hotchkis & Wiley Continues to Buy
Feb 14 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close16.80
Today’s open16.92
Day’s range16.60 - 17.17
Volume2,193,475
Average volume (3 months)3,430,131
Market cap$1.6B
Data as of 4:02pm ET, 02/20/2018

Growth & Valuation

Earnings growth (last year)+78.72%
Earnings growth (this year)--
Earnings growth (next 5 years)-3.90%
Revenue growth (last year)+1.01%
P/E ratio9.1
Price/Sales2.30
Price/Book0.34

Competitors

 Today’s
change
Today’s
% change
AGNPRAAllergan plc-11.83-2.05%
AKRXAkorn Inc-0.26-0.82%
PBYIPuma Biotechnology I...0.000.00%
OPKOPKO Health Inc-0.16-4.16%
Data as of 4:00pm ET, 02/20/2018

Financials

Next reporting dateFebruary 27, 2018
EPS forecast (this quarter)$1.68
Annual revenue (last year)$3.4B
Annual profit (last year)$548.0M
Net profit margin14.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark C. Trudeau
Senior Vice President-
Global Operations
Frank Scholz
Corporate headquarters
Staines-Upon-Thames, Surrey

Forecasts